Cypermethrin (CYM), a type II pyrethroid, is widely used as an insecticide for agriculture and household. Cumulative evidence indicates that acute and chronic exposure to CYM might cause a number of health problems, such as cancer and neuronal system diseases. However, the molecular mechanism underlying this pathology is not known. The main objective of this study was to define the effects of CYM on macrophages and the implication of such effects in cancer metastasis and the potential mechanism involved. The effects of CYM on the macrophages were evaluated by detecting the expression of M1 and M2 macrophage polarization markers through ELISA, quantitative RT-PCR, and Western blot assay. Transwell and wound healing assays were used to test the migration of lung cancer cells after exposure to CYM in vitro and a metastasis animal model in vivo. Treatment with CYM significantly suppressed lipopolysaccharide (LPS)-induced M1 macrophage polarization and promoted a shift toward M2 macrophage status. Mechanistically, CYM downregulated miR-155 significantly, leading to enhanced expression of its target gene Bcl6, thereby reducing the expression of mitogen-activated protein kinase 4 (MKK4), an upstream kinase of c-Jun N-terminal kinases (JNK), and inhibiting JNK activation. Impaired JNK activation thus promoted a shift in macrophage polarization from the M1 to the M2 phenotype. Finally, CYM-treated macrophages promoted metastasis of Lewis lung cancer cells in both in vitro and in vivo models. Taken together, our findings show that CYM is able to inhibit the M1 polarization and promote the macrophages to the M2 phenotype, which plays an important role in tumor metastasis.
causing necrosis of liver cells (Kan et al., 2012) . In addition, CYM can damage the reproductive system in adult rats and severely impairs the blood-brain barrier in mice (Gupta et al., 2000; Li et al., 2013) . In recent years, CYM exposure has been associated with increased risk of cancer and immune system diseases in humans (George et al., 2011; Hemming et al., 1993; Martini et al., 2010; Shukla et al., 2002) , without much understanding of mechanisms involved. At present, CYM is classified as a "possible human carcinogen" by the U.S. Environmental Protection Agency.
Macrophages play important roles in carcinogenesis as they are the most abundant immunocytes in murine and human tumors, where they are called tumor-associated macrophages (Murray and Wynn, 2011) . Recent studies have demonstrated that tumor-associated macrophages are highly plastic and flexible; and they are involved not only in anti-tumor immunity but also in tumor-promoting processes in various cancers, depending on their polarization and activation status (Cardoso et al., 2014; Chen et al., 2012; Qian and Pollard, 2010; Rolny et al., 2011; Sica and Mantovani, 2012) . Macrophages polarize broadly into two distinct phenotypes depending on microenvironmental conditions (Hussell and Bell, 2014) . First, classically activated macrophages or M1 macrophages are induced by toll-like receptor ligands, such as LPS and they have the capacity to produce a large quantities of the proinflammatory cytokines such as IL-1b, TNF-a, IL-6, and reactive oxygen species (Sindrilaru et al., 2011) . Second, alternatively activated macrophages or M2 macrophages are generated by IL-4 and/or IL-13, and express high levels of M2-associated genes such as arginase 1 (Arg1), macrophage galactose-type calcium-type lectins1/2 (Mgl1/2), and Fizz1 (also known as Retnla) (Gautier et al., 2012; Raes et al., 2002a,b) . M1 macrophages play an important role in controlling infections and assisting the host against tumors, whereas M2 macrophages inhibit effector T cells and promote tumor progression (Martinez et al., 2009) . Deactivation of the M1-like phenotype is accompanied by polarization to the M2 phenotype, with up-regulation of M2-associated gene expression (Sica and Mantovani, 2012) . The transition from M1 to M2 macrophages status has been shown to be critical in both infections and carcinogenesis, resulting in an immunosuppressive environment which can abrogate antitumor immunity (Sica and Mantovani, 2012) . Given the important functions of M1 and M2-like macrophages in the processes of tumorigenesis and metastasis, we first investigated the effects of CYM on macrophage polarization, and the relevance of such effects in tumor promoting potential of CYM. Our results demonstrate that the miR-155/Bcl6/ MKK4/JNK axis plays a key role in the process.
MATERIALS AND METHODS
Ethics statement. All experimental procedures involving animals were approved by the Animal Ethics Committee of the School of Public Health, Zhejiang University and performed in accordance with the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Cell culture and generation of bone marrow-derived macrophages (BMDMs). RAW264.7 cells were obtained from the ATCC (Manassas, VA), and the culture condition was the same as our previous study (Huang et al., 2016) . To prepare BMDMs, C57BL/6 wild-type (WT) mice (6-8 weeks) were sacrificed and the macrophages isolated from their bone marrow. Cells were cultured in six-well plates in 10% fetal bovine serum with macrophage colony stimulating factor (M-CSF, 10 ng/mL; Peprotech, Rocky Hill, NJ). The culture medium was changed at the third day and cells were cultured for another 3 days, again in the presence of M-CSF.
Chemicals and antibodies. CYM, LPS, and propidium iodide were manufactured from Sigma Chemical Company (St. Louis, MO). Rabbit-or mouse-monoclonal antibodies specific for Bcl6, phospho-JNK1/2, and JNK1/2 were from Cell Signaling Technology (Danvers, MA). GAPDH antibody was provided by Multisciences Biotechnology (Hangzhou, China). The miRNA mimic, inhibitor and their controls were obtained by GIMA (Shanghai, China).
Cell viability assay. Cells were planted into six-well culture plates at a density of about 1 Â 10 5 cells per well and then treated with Figure 2 . CYM represses the expression of proinflammatory cytokines and promotes M2-type gene transcription in macrophages. A and B, RAW264.7 cells were treated with 0-200 lM CYM for 24 h, and then stimulated with LPS for 6 h. Relative mRNA levels of genes encoding proinflammatory cytokines TNF-a, IL-1b, and iNOS (A) and M2-type genes Arg1, Mgl2, and Fizz1 (B) were assayed by qRT-PCR. C and D, Bone marrow-derived mouse macrophages were treated with 0-200 lM CYM for 24 h and then stimulated with LPS for 6 h. Relative mRNA levels of genes encoding proinflammatory cytokines (C) and M2-type genes (D) were determined by qRT-PCR. GAPDH was used as control in all experiments. All results are presented as means 6 SD from three independent experiments. *p < .05 as compared with LPS treatment alone.
CYM. Cells were harvested and washed twice with PBS after one day, then resuspended in 500 mL PBS containing 5 mL PI (5 mg/ mL). The cells were immediately analyzed on an FC500 MCL flow cytometer (Beckman Coulter, Brea, CA).
Western blotting and quantitative RT-PCR analysis. The standard protocols of total protein extraction and subsequent Western blotting as well as RNA isolation and qRT-PCR were the same as our previous study (Lu et al., 2017) . 3 0 -UTR luciferase reporter assays. The Bcl6 3 0 -untranslated region (UTR) was synthesized by GIMA and cloned in pmirGLO vector (Promega, Fitchburg, WI). pMIR-Bcl6-mut was generated by cloning the mutated Bcl6 3 0 -UTR constructs into pmirGLO vector.
HEK-293 cells were co-transfected with pMIR-Bcl6, pMIR-Bcl6-mut, or the control vectors and the indicated miRNA mimic, inhibitor, or controls using siPORT NeoFX liposomes (Ambion, Austin, TX). Twenty-four hours later, the cells were collected according to the manufacturer's instructions and assayed for firefly and Renilla luciferase activities.
Wound healing assay. Lewis lung cancer cells (LLCs) were planted into six-well culture plates and grew to 70% confluence. To form an artificial wound, a pipette tip was used on the surface of the cells in each well. The cells were observed for 24 h under the conditional culture medium. Finally, the results analysis was performed as described before (Lu et al., 2017) .
Transwell assay. LLCs were seeded at a density of 5 Â 10 4 per well in serum-free medium (200 ll) in the upper chambers of transwell insert plates (8 lm pore size; Corning, Kaiserslautern, Germany). The lower chamber contained 0.6 ml conditioned medium. After 24 h, the cells were fixed by 4% paraformaldehyde for 10 min, and the 0.1% crystal violet was used to stain the cells for 5 min. The stained cells were counted using an Olympus AX70 fluorescent microscope. Five optical fields from each well were selected randomly and quantified.
Animal experiments. For the production of classically or alternatively activated macrophages, RAW264.7 cells were treated with CYM (200 lM) or LPS (100 ng/ml) for 24 h. The treated macrophages were co-injected intravenously with 5Â 10 5 LLCs in a ratio of 1:3 in 0.1 mL DMEM into C57BL/6 mice (n ¼ 6 mice per group). Twenty-one days later, the mice were sacrificed. Next their lungs tissue were removed and fixed in 4% formaldehyde and then stained with hematoxylin and eosin (HE). In one section every 200 lm throughout the whole lung, the number of metastases was counted and classified as small (diameter-<50 lm), medium (diameter 50-200 lm), or large (diameter->200 lm).
Statistical analysis. Each experiment was repeated at least 3 times. All data are expressed as means 6 standard deviation. Differences between groups were analyzed for significance by the Student t test or one-way ANOVA. Bonferroni analysis was used for pairwise comparisons between groups. P-values < .05 were considered statistically significant.
RESULTS

Effect of CYM on Macrophage Viability
To determine the effect of CYM on viability of RAW264.7 cells, the cells were treated with a serial concentrations of CYM for Western blot. In (C-F), GAPDH was used as control. All results are presented as means 6 SD from three independent experiments. *p < .05 as compared with control.
24 h, and cell viability was analyzed by PI staining and flow cytometry ( Figure 1A ). CYM caused no significant change in cell viability at concentrations up to 200 lM ( Figure 1B) . Therefore, that CYM concentration range was used for all subsequent experiments.
CYM Inhibits M1 Marker Gene Expression Although Promoting M2 Signature Gene Transcription
To determine the impact of CYM on macrophage activation and the subsequent inflammatory response, we first tested its effect on the expression of several prototypical markers of M1-like macrophages induced by LPS in RAW264.7 cells (Figure 2A) . Although the treatment of these macrophages with LPS alone (100 ng/mL) for 6 h significantly increased the expression of proinflammatory cytokine genes, including TNF-a, IL-1b, and the key M1 marker gene iNOS, the expression of these genes was reduced by pretreatment with CYM for 24 h. Notably, although the expression of M1-associated gene TNF-a did not show a consistent dose-dependent reduction in response to CYM, the expression of both IL-1b and iNOS was potently inhibited by CYM in a dose-dependent manner. In contrast, the expression of M2-type macrophage markers such as Arg1, Fizzl, and Mgl2 was increased by CYM treatment. Treatment with CYM at concentrations of 100 or 200 lM resulted in significant increases in the expression of these genes ( Figure 2B ). Similarly, in bone marrow-derived macrophages, CYM treatment decreased the expression levels of M1-associated genes such as TNF-a, IL-1b, and iNOS induced by LPS, whereas CYM treatment moderately increased expression of the M2-like macrophage markers, including Arg1, Fizzl, and Mgl2, in these cells (Figs. 2C and 2D ). These results thus suggest that CYM inhibits LPS-induced M1-type macrophage polarization and promotes a shift toward M2 polarization.
miR-155 Is Responsible for the Polarization of Macrophages by CYM
Because recent studies have indicated that miRNAs play an important role in regulation of macrophage differentiation and immune response (Hu et al., 2015; O'Connell et al., 2010) , For instance, miR-223 suppress proinflammatory activation of macrophages by suppressing Pknox1 (Zhuang et al., 2012) , miR124 promotes M2 polarization by acting on M1 genes (Ponomarev et al., 2011) , and miR-155 up-regulation can promote M1 phenotype (Cai et al., 2012) . We thus postulated that CYM downregulates M1-polarized macrophages via targeting miRNAs. To test this hypothesis, we treated RAW264.7 cells with LPS with or without CYM pretreatment for 24 h and profiled their miRNA expression. Real-time PCR showed that CYM (200 lM) suppressed LPS-induced miR-155 expression in RAW 264.7 cells by about 50% ( Figure 3A) . To determine whether miR-155 was involved in the regulation of macrophage polarization by CYM, we transfected RAW264.7 cells with an miR-155 mimic, an miR-155 inhibitor, or their respective controls. As shown in Figure 3B , transfection of these cells with the miR-155 mimic increased miR-155 expression, whereas transfection with the miR-155 inhibitor decreased miR-155 expression.
Interestingly, transfection with miR-155 mimic for 24 h increased the expression of M1-associated genes such as iNOS, IL-6, and TNF-a in RAW264.7 cells that were treated with CYM 24 h prior to LPS challenge. Conversely, the expression of M2-related genes, including Arg1, Fizzl, and Mgl2, was inhibited by miR-155 mimic transfection (Figs. 3C and 3D) . Consistently, the expression of iNOS, IL-6, and TNF-a was decreased in RAW264.7 cells transfected with an miR-155 inhibitor and treated with CYM 24 h prior to LPS stimulation. Strikingly, the miR-155 inhibitor increased transcription of Arg1, Fizzl, and Mgl2 (Figs. 3E and 3F ). Taken together, these data suggest that CYM is able to regulate macrophage polarization via modulating miR-155.
miR-155 Directly Targets Bcl6
We next searched for the target genes of miR-155 implicated in the regulatory role of CYM in macrophage polarization. It has been reported earlier that miR-155 directly targets the 3 0 -UTR of Bcl6 ( Figure 4A ) (Nazari-Jahantigh et al., 2012). To confirm that Bcl6 is a direct target of miR-155, the WT 3 0 -UTR of Bcl6 or a mutant 3 0 -UTR was cloned into the pmirGLO vector to obtain luciferase reporter constructs. We found that miR-155 mimic significantly inhibited the luciferase activity of cells transfected with the WT Bcl6 3 0 -UTR vector as compared with the control RNAs, whereas miR-155 inhibitor enhanced this activity ( Figure 4B ). Accordingly, treatment of RAW264.7 cells with a miR-155 mimic markedly reduced, whereas treatment with an miR-155 inhibitor significantly increased the expression level of Bcl6 (Figs. 4C and 4D ). These results thus indicate that Bcl6 is indeed a target of miR-155. Having confirmed that Bcl6, a master transcription regulator, is a target of miR-155, we next determined whether the inhibition of miR-155 by CYM would release the suppression of Bcl6 by miR-155. Indeed, the induction of Bcl6 by LPS was further enhanced by CYM treatment in RAW264.7 cells, at both the mRNA and protein levels (Figs. 4E and 4F) . Thus, our data collectively demonstrate that CYM is able to promote Bcl6 expression via suppression of miR-155.
Bcl6 Suppresses M1 Polarization and Promotes M2 Status in Macrophages Treated With CYM
After establishing the effect of CYM on the expression of Bcl6, we next determined the effect of Bcl6 on macrophage polarization. First, knockdown of Bcl6 by siRNA significantly reduced Bcl6 protein level ( Figure 5A ). To understand the molecular mechanisms underlying the regulatory effects of Bcl6 on macrophage polarization, we focused on JNK, a key member of the MAPK families, that are known to play important roles in regulation of many cellular processes, including proliferation, apoptosis, and differentiation (Dhanasekaran and Reddy, 2008; Wang et al., 2012) . More importantly, there is evidence demonstrating the important role of JNK in regulation of macrophage polarization (Han et al., 2013; Zhang et al., 2016) . Here we showed that Bcl6 knockdown enhanced phosphorylation of JNK ( Figure 5B) . Similarly, knockdown of Bcl6 increased M1-related genes expressions, such as TNF-a, IL-6, and iNOS, whereas suppressing the expression of M2-associated genes, including Arg1, Fizzl, and Mgl2 (Figs. 5C and 5D ). In contrast, overexpression of Bcl6 significantly inhibited JNK activation ( Figure 5E ) and upregulated M2-associated genes expressions, including Arg1 and Mgl2, whereas downregulating M1-related genes, such as TNF-a, IL-6, and iNOS (Figs. 5F and 5G) .
To further analyze the relevance of JNK activity in this context, we assessed the effect of CYM on JNK activation induced by LPS. As shown in Figure 5H , the treatment of RAW264.7 cells with CYM significantly reduced LPS-induced JNK phosphorylation. These data thus indicate that CYM is likely to target the miR-155/Bcl6/JNK pathway in the modulation of macrophage polarization.
Bcl6 Regulates JNK Activation Through MKK4 Next, we explored the mechanisms underlying Bcl6-mediated modulation of JNK activity during macrophage polarization induced by CYM. Because MKK4 is a key upstream JNK kinase mediating JNK phosphorylation and activation (Raman et al., 2007; Wada et al., 2001) , we investigated the possible involvement of MKK4 in Bcl6-JNK pathway. As shown in Figure 6A , overexpression of Bcl6 reduced the expression of MKK4, whereas inhibition of Bcl6 heightened MKK4 expression, suggesting that MKK4 is negatively regulated by Bcl6. Importantly, the reduction in MKK4 expression induced by Bcl6 overexpression subsequently reduced JNK activation, whereas inhibition of Bcl6 increased MKK4 expression and JNK phosphorylation in macrophages treated with CYM (Figs. 6B and 6C) . These results thus reveal that Bcl6 negatively regulates MKK4 expression and subsequently reduces JNK activation in macrophages undergoing polarization to M2.
The miRNA-155/Bcl6/MKK4/JNK Axis Is Crucial for Macrophage M2 Polarization Induced by CYM In light of this evidence that the miR-155/Bcl6/MKK4/JNK axis is implicated in CYM-mediated macrophage polarization, we then tested whether manipulation of miR-155, Bcl6, or MKK4 expression would affect the capacity of CYM to shape macrophage phenotypes. Knockdown of MKK4 by or suppression of JNK by a specific inhibitor in miR-155-overexpressing RAW264.7 cells could increase expression of the M2-related genes Mgl2 and Fizzl whereas suppressing M1-related genes IL-6 and TNF-a (Figs. 7A-D) . In contrast, knockdown of Bcl6 led to reduction of transcription of the M2-related genes and increased the expression of M1-related genes (Figs. 7E and 7F ). Taken together, these findings establish the importance of the miR-155/Bcl6/MKK4/ JNK axis in CYM-driven macrophage polarization toward M2-associated gene transcriptions.
CYM-Treated Macrophages Promote Migration of LLCs In Vitro
In view of the capacity of M2-type macrophages to promote cancer metastasis (Yamaguchi et al., 2016) , we next investigated the effect of CYM on the functional macrophage-cancer cell interaction. Macrophages were treated with LPS with or without CYM, the culture medium was used as the conditioned medium for testing the effects on cell migration. In the wound healing and transwell assays, conditioned medium from macrophages treated with CYM or combined LPS þ CYM promoted migration of lung cancer cells over 24 h compared with conditioned medium from macrophages treated with LPS only (Figs. 8A and 8B) . Furthermore, the mRNA expression of metastasis-related genes such as MMP10, MMP9, and CCL7 in macrophages treated with CYM or CYM þ LPS was significantly higher than in macrophages treated with LPS alone ( Figure 8C ).
CYM-Treated Macrophages Promote Metastasis of LLCs In Vivo
To determine the impact of CYM on tumor metastasis in vivo, we injected CYM-treated macrophages in a mouse model of lung cancer. Mice were intravenously injected with LLCs in combination with CYM-treated RAW264.7 cells, M1 macrophages, or untreated RAW264.7 cells. On day 21 after co-injection, the mice were euthanized and their lung tissues were removed and dissected. Representative HE-stained metastases in the lungs are shown in Figure 9A . The numbers of metastases were significantly higher in the mice co-injected with LLCs and CYM-polarized macrophages ( Figure 9B ). Altogether, these findings suggest the possibility that CYM is able to inhibit M1-like macrophages in the tumor microenvironment and shifts macrophage polarization toward M2-like macrophages with tumor metastasis potential.
DISCUSSION
In this study, we have showed for the first time that CYM, an important endocrine-disrupting chemical (Guo et al., 2017; McKinlay et al., 2008) , could promote tumor metastasis by inhibiting development of proinflammatory M1 macrophages and shifting macrophage polarization to the M2 phenotype. Our findings also suggest a novel underlying molecular mechanism for this shift. CYM represses expression of miR-155, leading to enhanced Bcl6 expression, thereby reducing MKK4 expression and inhibiting activation of JNK, which subsequently promotes the shift in macrophage polarization from the M1 to the M2 phenotype.
CYM has been found to have carcinogenic and cocarcinogenic potential, but it was thought to be only slightly toxic to mammals (George et al., 2011; Glickman and Lech, 1982 ; Figure 8 . CYM-treated macrophages promote migration of LLCs in vitro. A, For the wood-healing assay, LLCs were scratched with a pipette tip and then treated with medium conditioned with macrophages treated with LPS, CYM, or CYM þ LPS or control medium for 24 h. B, A trans-well assay was performed to evaluate the effect of medium conditioned by macrophages treated with LPS, CYM, or CYM þ LPS or control medium on migration of LLC cells over 24 h. C, RAW264.7 cells were treated with 0 or 200 lM CYM for 24 h and then stimulated with or without 100 ng/mL LPS for 6 h. Relative mRNA expression of metastasis-related genes MMP9, MMP10, and CCL7 was determined by qRT-PCR. All results are presented as means 6 SD from three independent experiments. *p < .05 as compared with LPS treatment alone. Hemming et al., 1993; Shukla et al., 2002) . It was reported that CYM has estrogen receptor activity and could facilitate cell proliferation (Jin et al., 2010) . At the same time, androgen receptor activity and thyroid receptor activity were also reported (Du et al., 2010; Pan et al., 2012) . These endocrine-disrupting activities may account for the carcinogenic and cocarcinogenic potential of CYM. In this study, we used a range of CYM concentrations (from 12.5 to 200 lM) which are not cytotoxic to macrophages (Figure 1 ) and also consistent with some of the earlier reports (Raszewski et al., 2015; Romero et al., 2017) . Under this condition, we found that CYM is able to promote tumor metastasis by targeting a specific miRNA, miR-155, which is consistent with previous studies focused on endocrine-disrupting chemicals (Teng et al., 2013; Tilghman et al., 2012) . miRNAs have been reported to modulate the threshold for triggering the dynamic macrophage polarization (Hu et al., 2015; Ponomarev et al., 2011; Zhuang et al., 2012) , which is associated with the environmental cues (Lodish et al., 2008) . Thus, miRNAs here function as a molecular bridge between CYM and macrophage polarization, which led to matastasis. We first discovered miR-155 as a novel molecular mediator for CYM regulation of macrophage polarization.
Next we attempted to elucidate the effective molecules downstream of Bcl6 in regulation of macrophage polarization induced by CYM. We showed that Bcl6 inhibited MKK4 expression, which was consistent with the proven viewpoint that Bcl6 is a transcription repressor during immune responses (Chung et al., 2011; Hatzi and Melnick, 2014; Johnston et al., 2009; Yu et al., 2009) . MKK4 can be activated by the majority of MKKKs such as MEKK and TAK, and it phosphorylates the tyrosine residue of JNKs (Raman et al., 2007; Wada et al., 2001) . Previous studies have also suggested that the JNK signaling pathway plays a significant role in inflammation by mediating the polarization of macrophages (Han et al., 2013; Zhang et al., 2016) . Our results thus reveal the important role of JNK in CYM-induced polarization of macrophages to the M2 via this particular signaling axis of Bcl6/MKK4/JNK.
It is well known that M2-like tumor-associated macrophages in the cancer microenvironment promote tumor cell migration and invasion (Sica et al., 2008) . Our study examined the relationship between macrophages and the metastasis-promoting effect of CYM. Because one of the most common exposures to CYM in the environment is through the respiratory system, and CYM can induce oxidative damage and inflammation in lung tissue (Arafa et al., 2015) , we provided clear evidence showing that the metastasis-promoting effect of CYM in lung cancer models in vivo and in vitro could be partially attributed to the Figure 9 . CYM-treated macrophages promote tumor metastasis in vivo. Six-to 8-week-old C57BL/6 mice were injected intravenously with LLCs alone or in combination with RAW264.7 cells not treated or exposed to 200 lM CYM or 100 ng/mL LPS for 24 h. After 21 days, the mice were sacrificed and their lungs were removed and subjected to histologic analysis for metastases. A, HE staining highlighted small (diameter <50 lm), medium-sized (diameter 50-200 lm), and large (diameter > 200 lm) lung metastases. B, The total number of metastases per lung was determined (n ¼ 6 per group).
shift in macrophage polarization from the M1 to the M2 type. But whether such a mechanism of CYM is applicable to other types of cancers awaits further investigation. Our findings also indicate that the potential regulatory effect of CYM on macrophages can be achieved at the low and cytotoxic concentrations, indicating the important implication in public health. Our findings might provide important clues for a comprehensive assessment of CYM hazardous effects, including the potential effects of CYM on immunotoxicity and tumor metastasis and eventually support the development of novel preventive modalities to improve human health.
